Recruiting Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio NCT05655949 Conditions Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +14 more Locations Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States View Trial Details
Active, Not Recruiting Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma NCT04708067 Conditions Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +9 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer NCT04941287 Conditions Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +20 more Locations Mayo Clinic Hospital in Arizona — Phoenix, Arizona, United States City of Hope Comprehensive Cancer Center — Duarte, California, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States View all 29 locations View more locations Show fewer locations Loading locations... View Trial Details
